Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global 20s Proteasome Market Growth 2022-2028

  • LP 4922703
  • 78 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of 20s Proteasome will have significant change from previous year. According to our (LP Information) latest study, the global 20s Proteasome market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global 20s Proteasome market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States 20s Proteasome market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global 20s Proteasome market, reaching US$ million by the year 2028. As for the Europe 20s Proteasome landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main 20s Proteasome players cover Amgen Inc, Celgene Corp, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of 20s Proteasome market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Marizomib

Oprozomib

Carfilzomib

VPEA-002

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Colon Cancer

Lymphoma

Malignant Glioma

Neuroendocrine Cancer

Ovarian Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Amgen Inc

Celgene Corp

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global 20s Proteasome Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for 20s Proteasome by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for 20s Proteasome by Country/Region, 2017, 2022 & 2028

2.2 20s Proteasome Segment by Type

2.2.1 Marizomib

2.2.2 Oprozomib

2.2.3 Carfilzomib

2.2.4 VPEA-002

2.2.5 Others

2.3 20s Proteasome Sales by Type

2.3.1 Global 20s Proteasome Sales Market Share by Type (2017-2022)

2.3.2 Global 20s Proteasome Revenue and Market Share by Type (2017-2022)

2.3.3 Global 20s Proteasome Sale Price by Type (2017-2022)

2.4 20s Proteasome Segment by Application

2.4.1 Colon Cancer

2.4.2 Lymphoma

2.4.3 Malignant Glioma

2.4.4 Neuroendocrine Cancer

2.4.5 Ovarian Cancer

2.4.6 Others

2.5 20s Proteasome Sales by Application

2.5.1 Global 20s Proteasome Sale Market Share by Application (2017-2022)

2.5.2 Global 20s Proteasome Revenue and Market Share by Application (2017-2022)

2.5.3 Global 20s Proteasome Sale Price by Application (2017-2022)

3 Global 20s Proteasome by Company

3.1 Global 20s Proteasome Breakdown Data by Company

3.1.1 Global 20s Proteasome Annual Sales by Company (2020-2022)

3.1.2 Global 20s Proteasome Sales Market Share by Company (2020-2022)

3.2 Global 20s Proteasome Annual Revenue by Company (2020-2022)

3.2.1 Global 20s Proteasome Revenue by Company (2020-2022)

3.2.2 Global 20s Proteasome Revenue Market Share by Company (2020-2022)

3.3 Global 20s Proteasome Sale Price by Company

3.4 Key Manufacturers 20s Proteasome Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers 20s Proteasome Product Location Distribution

3.4.2 Players 20s Proteasome Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for 20s Proteasome by Geographic Region

4.1 World Historic 20s Proteasome Market Size by Geographic Region (2017-2022)

4.1.1 Global 20s Proteasome Annual Sales by Geographic Region (2017-2022)

4.1.2 Global 20s Proteasome Annual Revenue by Geographic Region

4.2 World Historic 20s Proteasome Market Size by Country/Region (2017-2022)

4.2.1 Global 20s Proteasome Annual Sales by Country/Region (2017-2022)

4.2.2 Global 20s Proteasome Annual Revenue by Country/Region

4.3 Americas 20s Proteasome Sales Growth

4.4 APAC 20s Proteasome Sales Growth

4.5 Europe 20s Proteasome Sales Growth

4.6 Middle East & Africa 20s Proteasome Sales Growth

5 Americas

5.1 Americas 20s Proteasome Sales by Country

5.1.1 Americas 20s Proteasome Sales by Country (2017-2022)

5.1.2 Americas 20s Proteasome Revenue by Country (2017-2022)

5.2 Americas 20s Proteasome Sales by Type

5.3 Americas 20s Proteasome Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC 20s Proteasome Sales by Region

6.1.1 APAC 20s Proteasome Sales by Region (2017-2022)

6.1.2 APAC 20s Proteasome Revenue by Region (2017-2022)

6.2 APAC 20s Proteasome Sales by Type

6.3 APAC 20s Proteasome Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe 20s Proteasome by Country

7.1.1 Europe 20s Proteasome Sales by Country (2017-2022)

7.1.2 Europe 20s Proteasome Revenue by Country (2017-2022)

7.2 Europe 20s Proteasome Sales by Type

7.3 Europe 20s Proteasome Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa 20s Proteasome by Country

8.1.1 Middle East & Africa 20s Proteasome Sales by Country (2017-2022)

8.1.2 Middle East & Africa 20s Proteasome Revenue by Country (2017-2022)

8.2 Middle East & Africa 20s Proteasome Sales by Type

8.3 Middle East & Africa 20s Proteasome Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of 20s Proteasome

10.3 Manufacturing Process Analysis of 20s Proteasome

10.4 Industry Chain Structure of 20s Proteasome

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 20s Proteasome Distributors

11.3 20s Proteasome Customer

12 World Forecast Review for 20s Proteasome by Geographic Region

12.1 Global 20s Proteasome Market Size Forecast by Region

12.1.1 Global 20s Proteasome Forecast by Region (2023-2028)

12.1.2 Global 20s Proteasome Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global 20s Proteasome Forecast by Type

12.7 Global 20s Proteasome Forecast by Application

13 Key Players Analysis

13.1 Amgen Inc

13.1.1 Amgen Inc Company Information

13.1.2 Amgen Inc 20s Proteasome Product Offered

13.1.3 Amgen Inc 20s Proteasome Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Amgen Inc Main Business Overview

13.1.5 Amgen Inc Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. 20s Proteasome Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. 20s Proteasome Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Marizomib

Table 4. Major Players of Oprozomib

Table 5. Major Players of Carfilzomib

Table 6. Major Players of VPEA-002

Table 7. Major Players of Others

Table 8. Global 20s Proteasome Sales by Type (2017-2022) & (K Pcs)

Table 9. Global 20s Proteasome Sales Market Share by Type (2017-2022)

Table 10. Global 20s Proteasome Revenue by Type (2017-2022) & ($ million)

Table 11. Global 20s Proteasome Revenue Market Share by Type (2017-2022)

Table 12. Global 20s Proteasome Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global 20s Proteasome Sales by Application (2017-2022) & (K Pcs)

Table 14. Global 20s Proteasome Sales Market Share by Application (2017-2022)

Table 15. Global 20s Proteasome Revenue by Application (2017-2022)

Table 16. Global 20s Proteasome Revenue Market Share by Application (2017-2022)

Table 17. Global 20s Proteasome Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global 20s Proteasome Sales by Company (2020-2022) & (K Pcs)

Table 19. Global 20s Proteasome Sales Market Share by Company (2020-2022)

Table 20. Global 20s Proteasome Revenue by Company (2020-2022) ($ Millions)

Table 21. Global 20s Proteasome Revenue Market Share by Company (2020-2022)

Table 22. Global 20s Proteasome Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers 20s Proteasome Producing Area Distribution and Sales Area

Table 24. Players 20s Proteasome Products Offered

Table 25. 20s Proteasome Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global 20s Proteasome Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global 20s Proteasome Sales Market Share Geographic Region (2017-2022)

Table 30. Global 20s Proteasome Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global 20s Proteasome Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global 20s Proteasome Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global 20s Proteasome Sales Market Share by Country/Region (2017-2022)

Table 34. Global 20s Proteasome Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global 20s Proteasome Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas 20s Proteasome Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas 20s Proteasome Sales Market Share by Country (2017-2022)

Table 38. Americas 20s Proteasome Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas 20s Proteasome Revenue Market Share by Country (2017-2022)

Table 40. Americas 20s Proteasome Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas 20s Proteasome Sales Market Share by Type (2017-2022)

Table 42. Americas 20s Proteasome Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas 20s Proteasome Sales Market Share by Application (2017-2022)

Table 44. APAC 20s Proteasome Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC 20s Proteasome Sales Market Share by Region (2017-2022)

Table 46. APAC 20s Proteasome Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC 20s Proteasome Revenue Market Share by Region (2017-2022)

Table 48. APAC 20s Proteasome Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC 20s Proteasome Sales Market Share by Type (2017-2022)

Table 50. APAC 20s Proteasome Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC 20s Proteasome Sales Market Share by Application (2017-2022)

Table 52. Europe 20s Proteasome Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe 20s Proteasome Sales Market Share by Country (2017-2022)

Table 54. Europe 20s Proteasome Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe 20s Proteasome Revenue Market Share by Country (2017-2022)

Table 56. Europe 20s Proteasome Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe 20s Proteasome Sales Market Share by Type (2017-2022)

Table 58. Europe 20s Proteasome Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe 20s Proteasome Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa 20s Proteasome Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa 20s Proteasome Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa 20s Proteasome Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa 20s Proteasome Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa 20s Proteasome Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa 20s Proteasome Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa 20s Proteasome Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa 20s Proteasome Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of 20s Proteasome

Table 69. Key Market Challenges & Risks of 20s Proteasome

Table 70. Key Industry Trends of 20s Proteasome

Table 71. 20s Proteasome Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. 20s Proteasome Distributors List

Table 74. 20s Proteasome Customer List

Table 75. Global 20s Proteasome Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global 20s Proteasome Sales Market Forecast by Region

Table 77. Global 20s Proteasome Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global 20s Proteasome Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas 20s Proteasome Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas 20s Proteasome Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC 20s Proteasome Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC 20s Proteasome Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe 20s Proteasome Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe 20s Proteasome Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa 20s Proteasome Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa 20s Proteasome Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global 20s Proteasome Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global 20s Proteasome Sales Market Share Forecast by Type (2023-2028)

Table 89. Global 20s Proteasome Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global 20s Proteasome Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global 20s Proteasome Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global 20s Proteasome Sales Market Share Forecast by Application (2023-2028)

Table 93. Global 20s Proteasome Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global 20s Proteasome Revenue Market Share Forecast by Application (2023-2028)

Table 95. Amgen Inc Basic Information, 20s Proteasome Manufacturing Base, Sales Area and Its Competitors

Table 96. Amgen Inc 20s Proteasome Product Offered

Table 97. Amgen Inc 20s Proteasome Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Amgen Inc Main Business

Table 99. Amgen Inc Latest Developments

Table 100. Celgene Corp Basic Information, 20s Proteasome Manufacturing Base, Sales Area and Its Competitors

Table 101. Celgene Corp 20s Proteasome Product Offered

Table 102. Celgene Corp 20s Proteasome Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Celgene Corp Main Business

Table 104. Celgene Corp Latest Developments

List of Figures

Figure 1. Picture of 20s Proteasome

Figure 2. 20s Proteasome Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global 20s Proteasome Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global 20s Proteasome Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. 20s Proteasome Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Marizomib

Figure 10. Product Picture of Oprozomib

Figure 11. Product Picture of Carfilzomib

Figure 12. Product Picture of VPEA-002

Figure 13. Product Picture of Others

Figure 14. Global 20s Proteasome Sales Market Share by Type in 2021

Figure 15. Global 20s Proteasome Revenue Market Share by Type (2017-2022)

Figure 16. 20s Proteasome Consumed in Colon Cancer

Figure 17. Global 20s Proteasome Market: Colon Cancer (2017-2022) & (K Pcs)

Figure 18. 20s Proteasome Consumed in Lymphoma

Figure 19. Global 20s Proteasome Market: Lymphoma (2017-2022) & (K Pcs)

Figure 20. 20s Proteasome Consumed in Malignant Glioma

Figure 21. Global 20s Proteasome Market: Malignant Glioma (2017-2022) & (K Pcs)

Figure 22. 20s Proteasome Consumed in Neuroendocrine Cancer

Figure 23. Global 20s Proteasome Market: Neuroendocrine Cancer (2017-2022) & (K Pcs)

Figure 24. 20s Proteasome Consumed in Ovarian Cancer

Figure 25. Global 20s Proteasome Market: Ovarian Cancer (2017-2022) & (K Pcs)

Figure 26. 20s Proteasome Consumed in Others

Figure 27. Global 20s Proteasome Market: Others (2017-2022) & (K Pcs)

Figure 28. Global 20s Proteasome Sales Market Share by Application (2017-2022)

Figure 29. Global 20s Proteasome Revenue Market Share by Application in 2021

Figure 30. 20s Proteasome Revenue Market by Company in 2021 ($ Million)

Figure 31. Global 20s Proteasome Revenue Market Share by Company in 2021

Figure 32. Global 20s Proteasome Sales Market Share by Geographic Region (2017-2022)

Figure 33. Global 20s Proteasome Revenue Market Share by Geographic Region in 2021

Figure 34. Global 20s Proteasome Sales Market Share by Region (2017-2022)

Figure 35. Global 20s Proteasome Revenue Market Share by Country/Region in 2021

Figure 36. Americas 20s Proteasome Sales 2017-2022 (K Pcs)

Figure 37. Americas 20s Proteasome Revenue 2017-2022 ($ Millions)

Figure 38. APAC 20s Proteasome Sales 2017-2022 (K Pcs)

Figure 39. APAC 20s Proteasome Revenue 2017-2022 ($ Millions)

Figure 40. Europe 20s Proteasome Sales 2017-2022 (K Pcs)

Figure 41. Europe 20s Proteasome Revenue 2017-2022 ($ Millions)

Figure 42. Middle East & Africa 20s Proteasome Sales 2017-2022 (K Pcs)

Figure 43. Middle East & Africa 20s Proteasome Revenue 2017-2022 ($ Millions)

Figure 44. Americas 20s Proteasome Sales Market Share by Country in 2021

Figure 45. Americas 20s Proteasome Revenue Market Share by Country in 2021

Figure 46. United States 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 47. Canada 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 48. Mexico 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 49. Brazil 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 50. APAC 20s Proteasome Sales Market Share by Region in 2021

Figure 51. APAC 20s Proteasome Revenue Market Share by Regions in 2021

Figure 52. China 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 53. Japan 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 54. South Korea 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 55. Southeast Asia 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 56. India 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 57. Australia 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 58. Europe 20s Proteasome Sales Market Share by Country in 2021

Figure 59. Europe 20s Proteasome Revenue Market Share by Country in 2021

Figure 60. Germany 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 61. France 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 62. UK 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 63. Italy 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 64. Russia 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 65. Middle East & Africa 20s Proteasome Sales Market Share by Country in 2021

Figure 66. Middle East & Africa 20s Proteasome Revenue Market Share by Country in 2021

Figure 67. Egypt 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 68. South Africa 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 69. Israel 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 70. Turkey 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 71. GCC Country 20s Proteasome Revenue Growth 2017-2022 ($ Millions)

Figure 72. Manufacturing Cost Structure Analysis of 20s Proteasome in 2021

Figure 73. Manufacturing Process Analysis of 20s Proteasome

Figure 74. Industry Chain Structure of 20s Proteasome

Figure 75. Channels of Distribution

Figure 76. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390